These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4951587)

  • 21. Re: Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    O'Croinin F; Zibin T
    J Psychiatry Neurosci; 1994 May; 19(3):226. PubMed ID: 8031748
    [No Abstract]   [Full Text] [Related]  

  • 22. Chlorpromazine epithelial keratopathy.
    Johnson AW; Buffaloe WJ
    Arch Ophthalmol; 1966 Nov; 76(5):664-7. PubMed ID: 6005949
    [No Abstract]   [Full Text] [Related]  

  • 23. In vivo observations of chlorpromazine ocular deposits in a patient on long-term chlorpromazine therapy.
    Razeghinejad MR; Nowroozzadeh MH; Zamani M; Amini N
    Clin Exp Ophthalmol; 2008 Aug; 36(6):560-3. PubMed ID: 18954320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phototoxic corneal and lens opacities in dogs receiving a fungicide, 2,6-dichloro-4-nitroaniline.
    Bernstein HN; Curtis J; Earl FL; Kuwabara T
    Arch Ophthalmol; 1970 Mar; 83(3):336-48. PubMed ID: 5415852
    [No Abstract]   [Full Text] [Related]  

  • 25. Chlorpromazine dose for people with schizophrenia.
    de Haan S; Liu X
    Schizophr Bull; 2009 May; 35(3):491-2. PubMed ID: 19342426
    [No Abstract]   [Full Text] [Related]  

  • 26. SKIN PIGMENTATION AND CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY.
    GREINER AC; BERRY K
    Can Med Assoc J; 1964 Mar; 90(11):663-5. PubMed ID: 14127375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chlorpromazine-induced retinopathy.
    Mitchell AC; Brown KW
    Br J Psychiatry; 1995 Jun; 166(6):822-3. PubMed ID: 7663839
    [No Abstract]   [Full Text] [Related]  

  • 28. LENTICULAR AND CORNEAL OPACITIES DURING PHENOTHIAZINE THERAPY.
    BARSA JA; NEWTON JC; SAUNDERS JC
    JAMA; 1965 Jul; 193():10-2. PubMed ID: 14297702
    [No Abstract]   [Full Text] [Related]  

  • 29. Ocular changes and phenothiazine derivatives in long-term residents of a mental retardation center.
    Gowdey CW; Coleman LM; Crawford EM
    Psychiatr J Univ Ott; 1985 Dec; 10(4):248-53. PubMed ID: 2868472
    [No Abstract]   [Full Text] [Related]  

  • 30. Long term evolution of the side-effect lens opacities induced by chlorpromazine prolonged therapy.
    Baron JB; Rivoalan Y; Morel P
    Agressologie; 1971; 12(1):57-60. PubMed ID: 5088348
    [No Abstract]   [Full Text] [Related]  

  • 31. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472
    [No Abstract]   [Full Text] [Related]  

  • 32. [An evaluation of single or multiple dosage of antipsychotic agents in the treatment of schizophrenia].
    Jiang ZN
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Feb; 19(1):41-3. PubMed ID: 3743245
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of corneal exposure in cataract formation in DFP-treated guinea pigs.
    Bronson LJ; Lazar M
    Am J Ophthalmol; 1970 May; 69(5):858-60. PubMed ID: 5441357
    [No Abstract]   [Full Text] [Related]  

  • 34. SKIN PIGMENTATION, CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE TREATMENT.
    MASSEY LW
    Can Med Assoc J; 1965 Jan; 92(4):186-7. PubMed ID: 14232196
    [No Abstract]   [Full Text] [Related]  

  • 35. Toxic psychosis induced by high-dosage chlorpromazine therapy.
    Beszterczey A; Pecknold JC
    Can Med Assoc J; 1971 May; 104(10):884 passim. PubMed ID: 5574054
    [No Abstract]   [Full Text] [Related]  

  • 36. Lenticular deposits associated with chloroquine Keratopathy.
    Lal S; Gupta AK
    Indian J Ophthalmol; 1974 Jun; 22(2):34-5. PubMed ID: 4461692
    [No Abstract]   [Full Text] [Related]  

  • 37. Corneal opacities after cataract surgery with hypromellose.
    Newton JN; Roberts CJ; Canning C
    Lancet; 2000 Jan; 355(9200):290. PubMed ID: 10675083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chlorpromazine-induced refractile corneal deposits and cataract.
    Leung AT; Cheng AC; Chan WM; Lam DS
    Arch Ophthalmol; 1999 Dec; 117(12):1662-3. PubMed ID: 10604679
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ocular changes in chlorpromazine-induced melanosis].
    Schönthaler M
    Klin Oczna; 1984 Nov; 86(11):491-2. PubMed ID: 6535884
    [No Abstract]   [Full Text] [Related]  

  • 40. Inadvertent intracorneal and intraocular corticosteroid injection.
    DeAngelis DD; Lee HM; Rootman DS
    Can J Ophthalmol; 2000 Aug; 35(5):273-4. PubMed ID: 10959468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.